Camden National Corporation’s Zoetis ZTS Stock Holding History

Camden National Corporation’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$10.3M	Buy	+65,409	New	+$10.4M	2.05%	12

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Camden National Corporation's ZTS Position: Q1 2021 in Review

Camden National Corporation opened a new position in Zoetis (ZTS) in Q1 2021: 65,409 shares worth $10.3M. The stake represents 2.05% of the portfolio and ranks #12 among its holdings.

1,414 funds tracked by Wall St. Rank hold ZTS as of Q1 2021.

Camden National Corporation held 65,409 shares of Zoetis worth $10.3M as of Q1 2021.
Zoetis was a new Camden National Corporation position in Q1 2021.
Zoetis made up 2.05% of Camden National Corporation's portfolio in Q1 2021, its #12 holding.
1,414 funds tracked by Wall St. Rank held Zoetis as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.